期刊文献+

PCNA和C-erbB-2在大肠癌组织中的表达及其意义 被引量:3

Expression of PCNA and C-erbB-2 proteins in large intestine cancer
在线阅读 下载PDF
导出
摘要 目的 :探讨PCNA和C -erbB - 2在大肠癌发病中的作用及其与病理分级 ,临床分期及预后的关系。方法 :应用免疫组化SP法对 5 2例大肠癌组织及癌旁粘膜进行检测。结果 :PCNA和C -erbB - 2在大肠癌组织均呈高表达 (P <0 0 5 ) ;与病理分级、临床分期及预后密切相关。结论 :PCNA和C -erbB - 2在大肠癌的发生和发展过程中起重要作用 ,提示PCNA和C -erbB - 2可作为判断大肠癌预后的标记物。 Objective:To investigate the roles of PCNA and C-erbB-2 proteins in the development of large intestine cancer and their relationships with pathological grade,clinic stage and prognosis.Methods:The immunohistochemical methods were adopted to examine the expression of PCNA and C-erbB-2 proteins in 52 cases with large intestine cancer and normal mucosa of paracancer.Results:Overexpression of PCNA and C-erbB-2 proteins were found in large intestine cancer( P <0 05);Their expression were closely association with tumor grades,stages and prognosis respectively.Conclusion:PCNA and C-erbB-2 proteins may play important roles in the development and progression of large intestine cancer.PCNA and C-erbB-2 proteins may be valuable markers for the evaluation of large intestine cancer prognosis.
机构地区 解放军第
出处 《临床肿瘤学杂志》 CAS 2002年第2期85-87,90,共4页 Chinese Clinical Oncology
关键词 大肠肿瘤 C-ERBB-2 增殖细胞核抗原 PCNA 免疫组化 病理分级 临床分期 预后 Large intestine neoplasm C-erbB-2 proteins Proliferating cell nuclear antigen Immunohistochemistry
  • 相关文献

参考文献1

共引文献14

同被引文献40

  • 1严伟国,韩俊毅,赵中辛.结肠肿瘤中KAI1基因表达的临床意义[J].南京医科大学学报(自然科学版),2005,25(7):492-494. 被引量:1
  • 2Vang R, Cooley I,D, Harrison WR, el al. Immunohisto- chemical determination of HER-2/neu expression in inva- sive breast carcinoma [J].Am J Clin Pathol,2000, 113(5): 669-674.
  • 3Pitti RM, Marsters SA, Lawrence DA, et al.Genomic am- plification of a decoy receptor fi~r Fas ligand in lung and colon cancer[J].Nature, 1998,396(6712):699-703.
  • 4Arakawa Y, Tachibana O, Hasegawa M, et al. Frequent gene amplifcation and overexpression of decoy receptor 3 in glioblastoma[J]. Acta Neuropathol, 2005, 109(3): 294-298.
  • 5Chen L, Tian X, Li W, et al. Expressions of Fas/DcR3 and RGD-Fasl, mediated apoplosis in pituitary adenomas [J]. Neurol India, 2009, 57(1): 28-30.
  • 6Macher-Goeppinger S, Auhnann S, Wagener N, et al. Decoy receptor 3 is a prognostic factor in renal cell cancer[J]. Neoplasia, 2008, 10(10): 1049-1056.
  • 7Li H, Zhang L, Lou H, et al. Overexpression of decoy receptor 3 in precancerous lesions and adenocarcinoma of the esophagus[J]. Am J Clin Pathol, 2005, 124(2): 282-287.
  • 8Mihl G, Bachmann F, Boulay JL, et al. DcR3 loctts is a predictive marker tbr 5-fuorouracil-based adjuvant chemotherapy in colorectal cancer[J]. Int J Cancer, 2002, 102(3): 254-257.
  • 9Bai C,Connolly B,Meteker ML,et ai.Overexpression of M86/DcR3 in human gastrointestinal tract tumors indepen- dent of gene amplification and its location in a four gene cluster[J].Proc Natl A cad Sci USA, 2000,97(3): 1230-1235.
  • 10Gill RM ,'Huntr JS.Soluble receptor(DeR3) and cellular in- hibitor of apoptosis-2 (cIAP-2) protect human cytotro- phoblast cells against LIGHT-mediated apoptosis [J].Am J Pathol, 2004, 165(1):309-317.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部